Evaluation of anticoagulation re-initiation practices following reversal of factor Xa inhibitors with andexanet alfa or 4F-PCC in patients with major bleeding events by Awatif Hafiz, Alshaya Abdulrahman I, Katelyn W. Sylvester, Jean M. Connors, Jessica Rimsans

Get full text

Comparison of 4F‐PCC in obese and nonobese patients with life‐threatening bleeding or requiring emergent surgery by Jessica Rimsans, Karen Berger, Sarah Culbreth, Christopher Hood, Katleen Chester, Jean M. Connors, Laurel Omert

Get full text

Heparin‐induced thrombocytopenia in end‐stage renal disease: Reliability of the PF4‐heparin ELISA by Julie Kelly, Katelyn W. Sylvester, Jessica Rimsans, Thomas D. Bernier, Clara Ting, Jean M. Connors

Get full text

Development of Multidisciplinary Anticoagulation Management Guidelines for Patients Receiving Durable Mechanical Circulatory Support by Amy A. Levesque PharmD, Andrea R. Lewin PharmD, Jessica Rimsans PharmD, Katelyn W. Sylvester PharmD, Lara Coakley NP, Frank Melanson RN, Hari Mallidi MD, Mandeep Mehra MD, Michael M. Givertz MD, Jean M. Connors MD

Get full text

Evaluation of Antifactor-Xa Heparin Assay and Activated Partial Thromboplastin Time Values in Patients on Therapeutic Continuous Infusion Unfractionated Heparin Therapy by Kevin McLaughlin PharmD, BCPS, Jessica Rimsans PharmD, BCPS, Katelyn W. Sylvester PharmD, BCPS, CACP, John Fanikos Rph, MBA, David M. Dorfman MD, PhD, Patricia Senna MT, ASCP, Jean M. Connors MD, Samuel Z. Goldhaber MD

Get full text